SCT510A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SCT510A, covering 2020-09-25 to 2023-02-16. Get the full timeline:
Most recent: Clinical Trial Update: This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD [Phase 3]